WO2006132176A1 - 注射針用接着剤と注射針の接着方法および注射器用フロントアセンブリ並びに注射器 - Google Patents
注射針用接着剤と注射針の接着方法および注射器用フロントアセンブリ並びに注射器 Download PDFInfo
- Publication number
- WO2006132176A1 WO2006132176A1 PCT/JP2006/311213 JP2006311213W WO2006132176A1 WO 2006132176 A1 WO2006132176 A1 WO 2006132176A1 JP 2006311213 W JP2006311213 W JP 2006311213W WO 2006132176 A1 WO2006132176 A1 WO 2006132176A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- needle
- adhesive
- base member
- syringe
- injection needle
- Prior art date
Links
- 239000000853 adhesive Substances 0.000 title claims abstract description 74
- 230000001070 adhesive effect Effects 0.000 title claims abstract description 74
- 238000000034 method Methods 0.000 title claims description 28
- 239000004844 aliphatic epoxy resin Substances 0.000 claims abstract description 33
- 238000010438 heat treatment Methods 0.000 claims abstract description 17
- 238000002347 injection Methods 0.000 claims description 77
- 239000007924 injection Substances 0.000 claims description 77
- 125000001931 aliphatic group Chemical group 0.000 claims description 35
- 230000001681 protective effect Effects 0.000 claims description 21
- 229920006332 epoxy adhesive Polymers 0.000 claims description 14
- IISBACLAFKSPIT-UHFFFAOYSA-N bisphenol A Chemical compound C=1C=C(O)C=CC=1C(C)(C)C1=CC=C(O)C=C1 IISBACLAFKSPIT-UHFFFAOYSA-N 0.000 claims description 13
- 239000003822 epoxy resin Substances 0.000 claims description 8
- 229920000647 polyepoxide Polymers 0.000 claims description 8
- 229920006122 polyamide resin Polymers 0.000 claims description 5
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims description 4
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 claims description 4
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 claims description 2
- 239000002253 acid Substances 0.000 claims description 2
- 239000010936 titanium Substances 0.000 claims description 2
- 229910052719 titanium Inorganic materials 0.000 claims description 2
- 230000001954 sterilising effect Effects 0.000 abstract description 20
- 239000004593 Epoxy Substances 0.000 abstract description 3
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 238000004659 sterilization and disinfection Methods 0.000 description 19
- 238000005259 measurement Methods 0.000 description 10
- 229940071643 prefilled syringe Drugs 0.000 description 10
- 239000000463 material Substances 0.000 description 7
- 239000003814 drug Substances 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 230000007547 defect Effects 0.000 description 4
- 239000000306 component Substances 0.000 description 3
- 238000007689 inspection Methods 0.000 description 3
- 239000004743 Polypropylene Substances 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000005426 pharmaceutical component Substances 0.000 description 2
- -1 polypropylene Polymers 0.000 description 2
- 229920001155 polypropylene Polymers 0.000 description 2
- 230000009257 reactivity Effects 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229910001220 stainless steel Inorganic materials 0.000 description 2
- 239000010935 stainless steel Substances 0.000 description 2
- RSWGJHLUYNHPMX-UHFFFAOYSA-N Abietic-Saeure Natural products C12CCC(C(C)C)=CC2=CCC2C1(C)CCCC2(C)C(O)=O RSWGJHLUYNHPMX-UHFFFAOYSA-N 0.000 description 1
- 229930185605 Bisphenol Natural products 0.000 description 1
- KHPCPRHQVVSZAH-HUOMCSJISA-N Rosin Natural products O(C/C=C/c1ccccc1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 KHPCPRHQVVSZAH-HUOMCSJISA-N 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 229920003002 synthetic resin Polymers 0.000 description 1
- 239000000057 synthetic resin Substances 0.000 description 1
- KHPCPRHQVVSZAH-UHFFFAOYSA-N trans-cinnamyl beta-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OCC=CC1=CC=CC=C1 KHPCPRHQVVSZAH-UHFFFAOYSA-N 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/28—Syringe ampoules or carpules, i.e. ampoules or carpules provided with a needle
- A61M5/284—Syringe ampoules or carpules, i.e. ampoules or carpules provided with a needle comprising means for injection of two or more media, e.g. by mixing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/32—Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles
- A61M5/34—Constructions for connecting the needle, e.g. to syringe nozzle or needle hub
- A61M5/349—Constructions for connecting the needle, e.g. to syringe nozzle or needle hub using adhesive bond or glues
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09J—ADHESIVES; NON-MECHANICAL ASPECTS OF ADHESIVE PROCESSES IN GENERAL; ADHESIVE PROCESSES NOT PROVIDED FOR ELSEWHERE; USE OF MATERIALS AS ADHESIVES
- C09J163/00—Adhesives based on epoxy resins; Adhesives based on derivatives of epoxy resins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/3129—Syringe barrels
- A61M2005/3132—Syringe barrels having flow passages for injection agents at the distal end of the barrel to bypass a sealing stopper after its displacement to this end due to internal pressure increase
Definitions
- the present invention relates to an adhesive used for adhering an injection needle and a method for adhering the injection needle. More specifically, the present invention relates to an adhesive for an injection needle and an injection that can improve the yield by suppressing the generation of foreign matter due to the adhesive. The present invention relates to a method for adhering a needle, a front assembly for a syringe using these, and a syringe.
- a syringe in which a front assembly including an injection needle, a needle base member, a protective cap, and a connection knob is fixed to the tip of a syringe barrel (see, for example, Patent Document 1) o
- the connection hub is firmly fixed to the tip of the syringe barrel in a tight manner, and the needle base member is detachably attached to the connection knob.
- the proximal end portion of the injection needle is fixed to the needle base member, and a protective cap is detachably attached so as to cover the periphery of the injection needle.
- the proximal end portion of the above-described injection needle is firmly fixed to the needle base member, and for example, is bonded with an epoxy adhesive mainly composed of bisphenol A type epoxy resin. That is, the proximal end portion of the injection needle is inserted into a through hole provided at the distal end of the needle base member, and an adhesive is tightly and thread-drawn between the proximal end portion of the injection needle and the needle base member. It is filled so as not to cause poor appearance.
- the adhesive has a viscosity set to about lOOOOmPa's by adjusting the content of the modified aliphatic epoxy resin.
- the needle base member is often formed of a synthetic resin material such as polypropylene resin, and the needle base member is heated during the curing.
- this adhesive is of a type that cures quickly at a relatively low temperature of around 100 ° C. For example, it is cured at 120 ° C or lower.
- the injection needle and the front assembly including the injection needle are assembled in the syringe manufacturing process, after being assembled with the syringe barrel, before filling the syringe with the syringe, or Prior to assembling with a syringe prefilled with the agent, sterilization is performed in a sterile room under steam and moist heat, for example, at 121 ° C.
- Patent Document 1 Japanese Utility Model Publication No. 10-211280
- the technical problem of the present invention is to solve the above-mentioned problems, suppress the generation of foreign substances caused by the adhesive, and improve the yield, and a method for bonding an adhesive for an injection needle and an injection needle. It is an object of the present invention to provide a syringe front assembly and a syringe.
- the present invention is configured as follows, for example, when FIG. 1 showing an embodiment of the present invention is also described based on FIG.
- the present invention 1 relates to an adhesive for an injection needle, which is an epoxy adhesive containing a modified aliphatic epoxy resin, and the base end of the injection needle (4) is connected to the syringe barrel (2) the needle at the tip.
- An adhesive for an injection needle that adheres to the base member (5), and has a viscosity of about 20000 mPa's or more.
- the viscosity of the adhesive may be about 20000 mPa's or more, but if it is excessively high, workability during filling may be deteriorated. For this reason, it is preferably set to about 40000 mPa's or less, more preferably about 30000 mPa's or less. As a result, the above-mentioned adhesive is easily filled between the injection needle and the needle base member without causing appearance defects due to stringing or the like.
- the content of the modified aliphatic epoxy resin is specifically set to about 10 to about 25% by weight, preferably about 20% by weight or less, based on the total amount of the epoxy adhesive.
- the adhesive may further contain bisphenol A type epoxy resin, modified polyamide resin, and titanium oxide.
- the present invention 2 also relates to a method for adhering a syringe needle, and a method for adhering a syringe needle in which a syringe needle (4) is bonded to a syringe base (2) with a needle base member (5) with an epoxy adhesive (19).
- the adhesive (19) is filled between the injection needle (4) and the needle base member (5), and then the adhesive (19) is heated to about 130 ° C or more and cured. It is characterized by making it.
- the curing temperature is set to a high temperature of about 130 ° C or higher, the polymerization reaction is sufficiently accelerated even if it contains a modified aliphatic epoxy resin having poor reactivity. Thus, unreacted products of the modified aliphatic epoxy resin remaining in the cured adhesive are reduced.
- the viscosity of the adhesive may be as low as, for example, lOOOOmPa's. Therefore, the adhesive can easily be inserted between the injection needle and the needle base member without causing appearance defects such as stringing. Filled.
- the heating temperature for curing the adhesive needs to be maintained at a temperature lower than the softening temperature of the needle base member. Accordingly, when the needle base member is made of, for example, polypropylene resin softened at about 160 ° C., the above curing temperature is preferably about 140 ° C. or less, more preferably It is set to about 130 ° C.
- this curing temperature should be in a range that does not adversely affect the injection needle, needle base member, or adhesive.
- this needle base member has a material strength with excellent heat resistance such as stainless steel
- the curing temperature can be set to a higher temperature, for example, about 150 ° C. to reduce the remaining amount of unreacted materials.
- the heating time for the above-described curing may be a time for sufficiently curing the epoxy resin. Specifically, for example, it is set to about 5 to about 30 minutes, preferably about 10 to about 20 minutes. If the heating time is short, not only the remaining amount of unreacted substances increases, but also there is a risk that the unreacted material will not be sufficiently cured. It is difficult to reduce the remaining amount of the product, and the efficiency of the curing process is reduced.
- the epoxy adhesive may contain bisphenol A type epoxy resin, modified aliphatic epoxy resin, modified polyamide resin, and titanium oxide.
- the content of the modified aliphatic epoxy resin is not limited to a specific value, but is usually set to about 10 to about 25% by weight, preferably about 20% by weight or less.
- the present invention 3 also relates to a front assembly for a syringe, comprising an injection needle (4), a needle base member (5), a connection screw, a hub (6), and a protective cap (7), wherein the above-mentioned injection needle (4) is fixed to the needle base member (5), the needle base member (5) is detachably attached to the connection node (6), and the connection hub (6) is an injection.
- the front cap for the syringe is provided with a connecting portion (17) fixed to the tip of the tube (2), and the protective cap (7) is detachably mounted so as to cover the periphery of the injection needle (4).
- the injection needle (4) and the needle base member (5) are fixed to each other by the injection needle adhesive (19) of the present invention 1 described above.
- the present invention 4 also relates to a front assembly for a syringe, comprising an injection needle (4), a needle base member (5), a connection screw, a hub (6), and a protective cap (7), wherein the above-mentioned injection needle (4) is fixed to the needle base member (5), the needle base member (5) is detachably attached to the connection node (6), and the connection hub (6) is an injection.
- the front cap for the syringe is provided with a connecting portion (17) fixed to the tip of the tube (2), and the protective cap (7) is detachably mounted so as to cover the periphery of the injection needle (4). It is pre, and the above-mentioned injection needle (4) and the above-mentioned needle base member (5) are fixed to each other by the above-mentioned injection needle adhesion method of the present invention 2.
- the present invention 5 relates to a syringe, wherein a needle base member (5) is attached to the tip of a syringe barrel (2), and the needle (4) is fixed to the needle base member (5).
- a protective cap (7) is detachably mounted in a state of covering the periphery of the above-described syringe needle (4), the needle base member (5), and the force. It is characterized by being fixed to each other by adhesive (19).
- the present invention 6 relates to a syringe, wherein a needle base member (5) is attached to the tip of a syringe barrel (2), and the needle (4) is fixed to the needle base member (5).
- a protective cap (7) is detachably mounted in a state of covering the periphery of the above-described needle, the needle (4), the needle base member (5), and the force. It is characterized by being fixed to each other by the bonding method described above.
- the syringe barrel is not limited to a specific shape or structure, and may be, for example, a one-chamber type prefilled syringe or a two-chamber type prefilled syringe or an unfilled syringe.
- the viscosity of the adhesive is set to about 20000 mPa's or more, the content of the modified aliphatic epoxy resin can be reduced, and the unmodified reaction of the modified aliphatic epoxy resin remaining after curing. Things can be reduced.
- the curing temperature is set to a high temperature of about 130 ° C. or higher, the reaction is sufficiently promoted even if the adhesive contains a modified aliphatic epoxy resin, and the modified fat remaining after curing. The unreacted product of the group epoxy resin can be reduced.
- the present invention can suppress the generation of foreign matters due to the adhesive, and can easily improve the yield in the manufacture of the syringe front assembly and the syringe.
- FIG. 1 is a cross-sectional view of a two-chamber prefilled syringe showing a first embodiment of the present invention.
- FIG. 2 is an enlarged cross-sectional view of the front assembly for a syringe according to the first embodiment.
- FIG. 3 is a cross-sectional view of a one-chamber prefilled syringe showing a second embodiment of the present invention.
- FIG. 4 is a comparison table 1 showing the relationship between the viscosity of the adhesive and the incidence of foreign matter.
- FIG. 5 is a comparison table 2 showing the relationship between the curing temperature of the adhesive and the foreign matter generation rate.
- FIG. 1 and 2 show a first embodiment of the present invention
- FIG. 1 is a sectional view of a two-chamber prefilled syringe
- FIG. 2 is an enlarged sectional view of a front assembly for a syringe.
- the syringe (1) has a syringe front assembly (3) fixed to the tip of a syringe barrel (2), and the front assembly (3) comprises a syringe needle (4) A needle base member (5), a connection hub (6), and a protective cap (7).
- the syringe barrel (2) has a front plug body (8), a middle plug body (9), and an end plug body (10).
- the first chamber (11) on the front side and the second chamber on the rear side. It is divided into (12).
- the first chamber (11) contains a powdery pharmaceutical component (13), and the second chamber (12) contains a solution or dispersion (14).
- a bypass (15) projects from the side wall of the syringe barrel (2).
- the middle plug (9) is advanced.
- the middle plug (9) reaches the bypass (15) formation position, the first chamber (11) and the second chamber (12) communicate with each other through the bypass (15).
- the solution (14) flows into the first chamber and the pharmaceutical component (13) is dissolved or dispersed.
- connection knob (6) includes a connection portion (17), and the connection portion (17) is externally fitted to the tip of the syringe barrel (2), and is firmly fixed in a tightly sealed manner.
- the needle base member (5) is detachably screwed to the distal end of the connection base (6).
- the distal end of the needle base member (5) There is a through hole (18).
- the injection needle (4) has a proximal end inserted into the through hole (18) and is securely fixed to the needle base member (5) with an epoxy adhesive (19).
- the protective cap (7) is detachably attached to the needle base member (5) so as to cover the periphery of the injection needle (4).
- the above-mentioned epoxy adhesive (19) is composed of a low-temperature fast-curing agent, specifically, a bisphenol A-type epoxy resin as a main component, and a modified aliphatic epoxy resin and a modified polyamide resin. Contains fat and acid titanium.
- the viscosity of this adhesive is mainly adjusted by the content of modified aliphatic epoxy resin in the range of about 10,000 to about 40,000 mPa's. The viscosity of this adhesive is reduced by reducing the content of modified aliphatic epoxy resin. I prefer it to be high.
- These epoxy adhesives (19) are cured by heating to about 120 ° C or higher, preferably about 130 ° C or higher.
- the injection needle (4) is previously bonded to the needle base member (5) with an epoxy adhesive (19), and this needle base member (5) is screwed and fixed to the tip of the connection knob (6). Attach the protective cap (7) around (4) and make the syringe front assembly (3) shown in Fig. 2 stand up.
- the front assembly (3) and the syringe barrel (2) in which the medicine component (13) and the solution or dispersion (14) are stored in each chamber (11, 12) in advance are aseptic. Sterilize indoors with steam at a specified temperature under humid heat.
- the connection part (17) of the connection sleeve (6) is fitted and fixed to the tip of the syringe barrel (2), and the rear of the syringe barrel (2).
- the finger grip (20) is fitted and fixed to the end, and the assembly of the syringe (1) is completed.
- the product with the plunger (16) screwed and fixed to the back of the end plug (10) is set in one set with the plunger (16) removed. May be.
- the syringe (1) After the above-described sterilization treatment or completion of the assembly process, the syringe (1) has foreign matters attached to the tip of the injection needle (4) and the inner surface of the protective cap (7). Then, an external inspection is performed.
- FIG. 3 is a cross-sectional view of a one-chamber prefilled syringe showing a second embodiment of the present invention.
- the inside of the syringe barrel (2) is partitioned as a chemical solution storage chamber (21) by the front plug (8) and end plug (10) so that the external force is tightly confined.
- (21) contains an injectable drug (22).
- a front assembly (3) is attached to the tip of a syringe barrel (2), and the front assembly (3) is connected to an injection needle (4) and a needle base member (5). It has a knob (6) and a protective cap (7), and the injection needle (4) and needle base member (5) are securely fixed with epoxy adhesive (19).
- Other configurations are the same as those in the first embodiment, and the description thereof will be omitted.
- the syringe (1) is sterilized by the following procedure in the assembly process.
- the front assembly (3) is assembled in the same manner as in the first embodiment, and the connection knob (6) of the front assembly (3) is externally fitted to the tip of the unfilled syringe barrel (2).
- the finger grip (20) is fitted and fixed to the rear end of the syringe barrel (2).
- the front assembly (3) is attached to the tip of the unfilled syringe barrel (2) and sterilized, and then injected into the syringe barrel (2) (22 ).
- the front assembly and the prefilled syringe can be sterilized and then assembled together.
- the front assembly and the prefilled syringe can be sterilized and then assembled together.
- Formulation of the adhesive used is bisphenol A type epoxy ⁇ 35-50 wt 0/0, denatured fat aliphatic epoxy ⁇ 10-25 wt%, modified polyamide ⁇ 20-35 wt%, titanium oxide 1 0 -20% by weight.
- Sterilization was carried out at 121 ° C with a heat load of 20 minutes or longer. After sterilization, the object to be sterilized was dried by repeatedly applying vacuum and return pressure while warming the inside of the machine.
- Example 1 Adhesion within 15 to 25% by weight of modified aliphatic epoxy resin The viscosity of the agent was adjusted to 20000 mPa's. The adhesive was cured by heating at 120 ° C for 20 minutes.
- Example 2 The viscosity of the adhesive was adjusted to 30000 mPa's when the content of the modified aliphatic epoxy resin was in the range of 10 to 20% by weight. The adhesive was cured by heating at 120 ° C for 20 minutes.
- Example 3 The viscosity of the adhesive was adjusted to lOOOOmPa's when the content of the modified aliphatic epoxy resin was 15 to 25% by weight. The adhesive was cured by heating at 130 ° C for 20 minutes.
- Example 4 The viscosity of the adhesive was adjusted to 20000 mPa's when the content of the modified aliphatic epoxy resin was 15 to 25% by weight. The adhesive was cured by heating at 130 ° C for 20 minutes.
- Example 5 The viscosity of the adhesive was adjusted to 30000 mPa's when the content of the modified aliphatic epoxy resin was in the range of 10 to 20% by weight. The adhesive was cured by heating at 130 ° C for 20 minutes. As a result of measurement after sterilization, there was no incidence of foreign matter.
- Example 3 As can be seen from the comparison between Example 3 and Comparative Example 1 in this measurement result, even when the content of the modified aliphatic epoxy resin and the viscosity of the adhesive are the same, the adhesion can be increased by increasing the curing temperature. It was found that the incidence of foreign substances caused by the agent can be greatly reduced and the yield can be greatly improved.
- the present invention makes it easy to bond the injection needle and the needle base member, and further, it is possible to improve the yield by suppressing the generation of foreign substances caused by the adhesive. It is a matter of course that it can be applied to other pre- syringe syringes, and the force that is suitable for the front assembly used for this.
Landscapes
- Health & Medical Sciences (AREA)
- Vascular Medicine (AREA)
- Engineering & Computer Science (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Adhesives Or Adhesive Processes (AREA)
Abstract
Description
Claims
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP06766450.8A EP1892005B1 (en) | 2005-06-06 | 2006-06-05 | Adhesive for syringe needle, method of adhering syringe needle, front assembly for syringe and syringe |
JP2007520089A JPWO2006132176A1 (ja) | 2005-06-06 | 2006-06-05 | 注射針用接着剤と注射針の接着方法および注射器用フロントアセンブリ並びに注射器 |
US11/921,574 US7967796B2 (en) | 2005-06-06 | 2006-06-05 | Adhesive for injection needle, a method for bonding injection needle, a syringe front-assembly and a syringe |
ES06766450.8T ES2438737T3 (es) | 2005-06-06 | 2006-06-05 | Adhesivo para aguja de jeringa, método de adhesión de aguja de jeringa, conjunto frontal para jeringa y jeringa |
CA2610562A CA2610562C (en) | 2005-06-06 | 2006-06-05 | An adhesive for injection needle, a method for bonding injection needle, a syringe front-assembly and a syringe |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005165083 | 2005-06-06 | ||
JP2005-165083 | 2005-06-06 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2006132176A1 true WO2006132176A1 (ja) | 2006-12-14 |
Family
ID=37498377
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2006/311213 WO2006132176A1 (ja) | 2005-06-06 | 2006-06-05 | 注射針用接着剤と注射針の接着方法および注射器用フロントアセンブリ並びに注射器 |
Country Status (6)
Country | Link |
---|---|
US (1) | US7967796B2 (ja) |
EP (1) | EP1892005B1 (ja) |
JP (1) | JPWO2006132176A1 (ja) |
CA (1) | CA2610562C (ja) |
ES (1) | ES2438737T3 (ja) |
WO (1) | WO2006132176A1 (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20140323986A1 (en) * | 2008-05-20 | 2014-10-30 | Hexal Ag | Method For Reducing Leachables and Extractables In Syringes |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2016350924A1 (en) | 2015-11-05 | 2018-05-31 | Tsk Laboratory Europe B.V. | Method for connecting two objects using a polymer composition and a system, for use in a cosmetic procedure |
JP7148602B2 (ja) | 2017-09-08 | 2022-10-05 | サムヤン ホールディングス コーポレイション | シーラントシリンジアセンブリ |
DE102019108583B4 (de) * | 2019-04-02 | 2023-02-09 | Gerresheimer Regensburg Gmbh | Verfahren zum Verbinden eines ersten Bauteils mit einem zweiten Bauteil |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5714437A (en) * | 1980-06-30 | 1982-01-25 | Hakko Denki Seisakusho:Kk | Production of injection needle and needle base thereof |
JPS6464670A (en) * | 1987-03-27 | 1989-03-10 | Becton Dickinson Co | Holder and method for assembling the same |
JPH1025391A (ja) * | 1996-07-09 | 1998-01-27 | Hitachi Chem Co Ltd | 硬化性組成物、その製造法及び硬化物の製造法 |
JPH10211280A (ja) | 1997-01-30 | 1998-08-11 | Takeda Chem Ind Ltd | 2室式容器兼用注射器 |
JPH11302358A (ja) * | 1998-04-22 | 1999-11-02 | Tomoegawa Paper Co Ltd | 光硬化性樹脂組成物 |
JP2002146321A (ja) * | 2000-11-16 | 2002-05-22 | Hitachi Chem Co Ltd | 接着剤組成物とその接着剤組成物を用いた接着部材と半導体搭載用基板並びに半導体装置 |
JP2004323589A (ja) * | 2003-04-22 | 2004-11-18 | Kanegafuchi Chem Ind Co Ltd | 硬化性接着剤組成物 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3430627A (en) * | 1963-06-10 | 1969-03-04 | Owens Illinois Inc | Hypodermic needle |
JPS6038767B2 (ja) * | 1978-07-26 | 1985-09-03 | 富士写真フイルム株式会社 | 磁気記録体 |
JPS59204675A (ja) * | 1983-05-04 | 1984-11-20 | Kanegafuchi Chem Ind Co Ltd | 耐熱性接着剤 |
US4808639A (en) * | 1986-07-16 | 1989-02-28 | Production Previews, Inc. | Liquid curable adhesive composition comprising a polyester resin and a microencapsulated peroxide curing agent |
JPH0639037A (ja) * | 1992-07-22 | 1994-02-15 | Three Bond Co Ltd | 注射針固定用の接着組成物 |
JPH06225940A (ja) * | 1993-02-02 | 1994-08-16 | Terumo Corp | 注射針 |
US5358491A (en) * | 1993-09-13 | 1994-10-25 | Sterling Winthrop Inc. | Cartridge-needle unit having retractable needle |
JPH07145225A (ja) * | 1993-11-22 | 1995-06-06 | Nissan Motor Co Ltd | 接着性エポキシ樹脂組成物 |
US6746428B2 (en) * | 2001-02-21 | 2004-06-08 | Becton, Dickinson And Company | High temperature dry heat sterilizable syringe barrel and needle cannula assembly |
JP2004099833A (ja) * | 2002-09-12 | 2004-04-02 | Three M Innovative Properties Co | 熱硬化性接着剤組成物、フィルム接着剤及び半導体装置 |
JP4300790B2 (ja) * | 2002-07-18 | 2009-07-22 | 住友金属鉱山株式会社 | 熱硬化型光学用接着剤とこの接着剤が適用された光アイソレータ素子および光アイソレータ |
JP2005307037A (ja) * | 2004-04-22 | 2005-11-04 | Nagase Chemtex Corp | フィルム状エポキシ樹脂組成物 |
-
2006
- 2006-06-05 CA CA2610562A patent/CA2610562C/en not_active Expired - Fee Related
- 2006-06-05 EP EP06766450.8A patent/EP1892005B1/en not_active Not-in-force
- 2006-06-05 WO PCT/JP2006/311213 patent/WO2006132176A1/ja active Application Filing
- 2006-06-05 ES ES06766450.8T patent/ES2438737T3/es active Active
- 2006-06-05 US US11/921,574 patent/US7967796B2/en not_active Expired - Fee Related
- 2006-06-05 JP JP2007520089A patent/JPWO2006132176A1/ja active Pending
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5714437A (en) * | 1980-06-30 | 1982-01-25 | Hakko Denki Seisakusho:Kk | Production of injection needle and needle base thereof |
JPS6464670A (en) * | 1987-03-27 | 1989-03-10 | Becton Dickinson Co | Holder and method for assembling the same |
JPH1025391A (ja) * | 1996-07-09 | 1998-01-27 | Hitachi Chem Co Ltd | 硬化性組成物、その製造法及び硬化物の製造法 |
JPH10211280A (ja) | 1997-01-30 | 1998-08-11 | Takeda Chem Ind Ltd | 2室式容器兼用注射器 |
JPH11302358A (ja) * | 1998-04-22 | 1999-11-02 | Tomoegawa Paper Co Ltd | 光硬化性樹脂組成物 |
JP2002146321A (ja) * | 2000-11-16 | 2002-05-22 | Hitachi Chem Co Ltd | 接着剤組成物とその接着剤組成物を用いた接着部材と半導体搭載用基板並びに半導体装置 |
JP2004323589A (ja) * | 2003-04-22 | 2004-11-18 | Kanegafuchi Chem Ind Co Ltd | 硬化性接着剤組成物 |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20140323986A1 (en) * | 2008-05-20 | 2014-10-30 | Hexal Ag | Method For Reducing Leachables and Extractables In Syringes |
US9895497B2 (en) * | 2008-05-20 | 2018-02-20 | Hexal Ag | Method for reducing leachables and extractables in syringes |
Also Published As
Publication number | Publication date |
---|---|
US7967796B2 (en) | 2011-06-28 |
US20090209919A1 (en) | 2009-08-20 |
JPWO2006132176A1 (ja) | 2009-01-08 |
ES2438737T3 (es) | 2014-01-20 |
EP1892005A1 (en) | 2008-02-27 |
CA2610562C (en) | 2013-12-24 |
EP1892005B1 (en) | 2013-09-25 |
CA2610562A1 (en) | 2006-12-14 |
EP1892005A4 (en) | 2012-06-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5189123B2 (ja) | 高温乾熱殺菌可能な皮下注射器外筒とニードルカニューレのアセンブリの作製方法 | |
TW200916138A (en) | Two-chamber carpule | |
WO2006132176A1 (ja) | 注射針用接着剤と注射針の接着方法および注射器用フロントアセンブリ並びに注射器 | |
WO2004037329A1 (ja) | シリンジ、キャップおよびプレフィルドシリンジの製造方法 | |
WO2012101669A1 (ja) | シリンジ用ガスケットおよびそれを用いたプレフィルドシリンジ | |
US20160082199A1 (en) | Syringe with injection needle and manufacturing method for syringe with injection needle | |
CN104497372B (zh) | 一种清洁无菌高阻隔性医用胶塞及其制备方法 | |
JPH0375185B2 (ja) | ||
JPWO2013065370A1 (ja) | 針付き外筒の製造方法及び針付き外筒 | |
CN107096090A (zh) | 储存诸如胰岛素的药物的容器 | |
WO2006058162A2 (en) | Orthodontic brackets having different adhesives and methods and appliances therewith | |
US10098812B2 (en) | Multi-component container | |
CN105086893A (zh) | 一种医用热熔胶及其制备方法 | |
JPS60241452A (ja) | 医療用針およびこれを有する医療用器具 | |
CN100398407C (zh) | 复膜胶塞及其制备方法 | |
JP2020529224A (ja) | 薬物容器用の充填−仕上げ支持体 | |
JP2010268883A (ja) | プレフィルドシリンジ用注射器およびプレフィルドシリンジ | |
JPH01135839A (ja) | 塩化ビニル樹脂製品の製法 | |
JPH0116186B2 (ja) | ||
EP2168560A2 (en) | Dental root canal-filling composition | |
CN102936389A (zh) | 一种复合生物可降解合成高分子材料及其合成方法 | |
JPH0243507B2 (ja) | ||
JP4289104B2 (ja) | 医療用具およびその製造方法 | |
JPH05115560A (ja) | 医療用器具およびその製造方法 | |
JPH0238023A (ja) | 筒体と接続部材の接続構造及びその接続構造を用いた医療用容器 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2007520089 Country of ref document: JP |
|
ENP | Entry into the national phase |
Ref document number: 2610562 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 11921574 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2006766450 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWP | Wipo information: published in national office |
Ref document number: 2006766450 Country of ref document: EP |